Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU) (MINVIFU)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2R3
- University of Alberta
-
-
New Brunswick
-
Dalhousie, New Brunswick, Canada, E8C 2R6
- Dalhousie University
-
-
-
-
-
Poznań, Poland
- Poznań University of Medical Science
-
-
-
-
California
-
Davis, California, United States, 95616
- University of California, Davis
-
Loma Linda, California, United States, 92350
- Loma Linda Medical Center
-
San Diego, California, United States, 92123
- Sharp Mary Birch Hospital for Women and Newborns
-
San Diego, California, United States, 91942
- Sharp Grossmont Hospital
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20052
- George Washington University
-
-
Oregon
-
Portland, Oregon, United States, 97225-6603
- Providence St. Vincent Medical Center
-
-
Utah
-
Salt Lake City, Utah, United States, 84113
- University of Utah/IMH
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Enrolled in the primary trial NCT:03631940 and parental written consent to participate in developmental follow-up through 2 years of age was obtained.
- Enrolled in the primary trial NCT:03631940 and did not survive to 2 years.
Exclusion Criteria:
- Enrolled in the primary trial NCT:03631940 but parent/guardian declined consent to developmental follow-up participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Umbilical Cord Milking
At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped.
|
At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped.
|
|
Active Comparator: Early Cord Clamping
The umbilical cord is clamped as soon as possible and within 60 seconds of delivery.
|
The umbilical cord is clamped as soon as possible and within 60 seconds of delivery.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total and Domain Scores on the Ages and Stages Questionnaire, Third Edition.
Time Frame: 22 to 26 months
|
Neurodevelopmental Outcome at 2 Years of Age defined as overall and domain scores on the Ages and Stages, third edition.
Questionnaire.
Minimum score of 0 and maximum score of 60 per domain.
Scores from 5 subscales are summed to obtain a total score.
5 domains assessed include communication, gross motor, fine motor, problem solving, personal social with a total minimum score of 0 and maximum score of 300.
Higher scores indicate a lower risk of developmental delays or conditions
|
22 to 26 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Score Ranges on the Modified Checklist for Autism in Toddlers Questionnaire
Time Frame: 22-26 months
|
Modified Checklist for Autism in Toddlers.
Minimum score of 0 and maximum score of 20.
Higher scores indicate higher risk for autism spectrum disorder.
Total scores of 0 to 2 indicates a low risk of autism spectrum disorder.
Total scores of 3 to 7 indicates a moderate risk of autism spectrum disorder.
Total scores of 8 to 20 indicate high risk of autism spectrum disorder.
|
22-26 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Anup Katheria, MD, Neonatologist
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MINVIFU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.